VIMIZIM® VIMIZIM® (elosulfase alfa) is the first and only enzyme replacement therapy approved for people with Morquio A. Productsparisiva—30 April 2022 Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0
